KEGG   DRUG: Apolizumab
Entry
D02967                      Drug                                   
Name
Apolizumab (USAN/INN)
Efficacy
Antineoplastic, Anti-HLA-DR antibody
  Type
Monoclonal antibody
Target
HLA-DRB [HSA:3123 3125 3126 3127] [KO:K06752]
  Pathway
hsa04514  Cell adhesion molecules
hsa04612  Antigen processing and presentation
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: Ig superfamiy
   MHC
    HLA-DRB
     D02967  Apolizumab (USAN/INN)
Other DBs
CAS: 267227-08-7
PubChem: 17397124

» Japanese version   » Back

DBGET integrated database retrieval system